Abarceo’s CEO Adam Bruce participated at the Almi Invest Rooftop Mingle on May 7th and gave an inspiring presentation. “I’m grateful for the opportunity to take part in this important event,” says Adam Bruce. ...
Abarceo is participating in the upcoming Redeye Theme Event Diabetes 2026! We’re proud to present Abarceo at the main diabetes business and finance event in Sweden, The Redeye Theme Event Diabetes 2026 on May 6! This focused seminar is intended to give investors...
Adam Bruce, CEO & Chair of Abarceo Pharma, presents at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to...
BioStock’s Natasha Bank interviews Adam Bruce, CEO & Chair of Abarceo Pharma, at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life...
Abarceo Pharma får Almi Invest som ny delägare när de nu tar in total 21,5 miljoner kroner. Pengarna ska räcka i ett år och bland annat användas för att bestämma vilken läkemedelskandidat som de ska utveckla vidare. Bolaget har i nuläget flera möjliga kandidater för...
Recent Comments